HPV Vaccination and the Risk of Invasive Cervical Cancer
New England Journal of MedicinePublished 30 September 2020Open access
Jiayao Lei, Alexander Ploner, K. Miriam Elfström, Jiangrong Wang, Adam Roth, Fang Fang
Citations1,359
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveWill appear once the snapshot is generated
MethodsWill appear once the snapshot is generated
PopulationWill appear once the snapshot is generated
Sample sizeWill appear once the snapshot is generated
OutcomesWill appear once the snapshot is generated
ResultsWill appear once the snapshot is generated
LimitationsWill appear once the snapshot is generated
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Among Swedish girls and women 10 to 30 years old, quadrivalent HPV vaccination was associated with a substantially reduced risk of invasive cervical cancer at the population level.
Abstract
Among Swedish girls and women 10 to 30 years old, quadrivalent HPV vaccination was associated with a substantially reduced risk of invasive cervical cancer at the population level. (Funded by the Swedish Foundation for Strategic Research and others.).
Keywords
Medicine
The Journal of PathologyHuman papillomavirus is a necessary cause of invasive cervical cancer worldwide
9,038 Citations1999Jan M.M. Walboomers, Marcel V. Jacobs +8 more
The presence of HPV in virtually all cervical cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer, and the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.
The LancetHuman papillomavirus and cervical cancer
2,991 Citations2007Mark Schiffman, Philip E. Castle +3 more
The new HPV-oriented model of cervical carcinogenesis should gradually replace older morphological models based only on cytology and histology, and can minimise the incidence of cervical cancer, and the morbidity and mortality it causes, even in low-resource settings.
Clinical Microbiology ReviewsHuman Papillomavirus and Cervical Cancer
2,422 Citations2003Eileen M. Burd
Currently, the clearest role for HPV DNA testing is to improve diagnostic accuracy and limit unnecessary colposcopy in patients with borderline or mildly abnormal cytologic test results.
European Journal of EpidemiologyThe Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
2,310 Citations2009Jonas F. Ludvigsson, P Otterblad-Olausson +2 more
The Swedish personal identity number (PIN) is described and it is suggested that matching of registers through PIN and matching of national health registers without the explicit approval of theindividual patient is to the benefit for both the individual patient and for society.
New England Journal of MedicineQuadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2,039 Citations2007Luisa L. Villa
In young women who had not been previously infected with HPV-16 or HPV-18, those in the vaccine group had a significantly lower occurrence of high-grade cervical intraepithelial neoplasia related to HPV- 16 or HPV -18 than did those inThe placebo group.
Pharmacoepidemiology and Drug SafetyThe new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months
1,875 Citations2006Björn Wettermark, Niklas Hammar +8 more
The content and potentials of the new Swedish national register on prescribed and dispensed medicines are described.
The LancetEfficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
1,637 Citations2009Jorma Paavonen, Paulo Naud +25 more
The HPV- 16/18 AS04-adjuvanted vaccine showed high efficacy against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic HPV types and substantial overall effect in cohorts that are relevant to universal mass vaccination and catch-up programmes.
European Journal of EpidemiologyRegisters of the Swedish total population and their use in medical research
1,535 Citations2016Jonas F. Ludvigsson, Catarina Almqvist +6 more
The two population registers in Sweden are described and their strengths and weaknesses are analyzed to determine the basis for correct decisions and measures by government and other regulatory authorities.
The LancetPopulation-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
1,262 Citations2019Mélanie Drolet, Élodie Bénard +49 more
The results show compelling evidence of the substantial impact of HPV vaccination programmes on HPV infections and CIN2+ among girls and women, and on anogenital warts diagnoses among girls, women, boys, and men.
Acta OncologicaThe completeness of the Swedish Cancer Register – a sample survey for year 1998
1,228 Citations2008Lotti Barlow, Kerstin Westergren +2 more
The overall completeness of the SCR is high and comparable to other high quality registers in Northern Europe, and the degree of underreporting is site specific, increases with age, and does not seem to be random.
The LancetHuman papillomavirus and cervical cancer
1,170 Citations2013Emma J. Crosbie, Mark H. Einstein +2 more
More sensitive than cytology, primary screening by human papillomavirus testing could enable screening intervals to be extended and if these prevention strategies can be implemented in developing countries, many thousands of lives could be saved.
JAMAEffect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection
657 Citations2007Allan Hildesheim, Rolando Herrero +11 more
In women positive for HPV DNA, HPV-16/18 vaccination does not accelerate clearance of the virus and should not be used to treat prevalent infections.
BMJEducational differences in smoking: international comparison
634 Citations2000Adriënne E.J.M. Cavelaars
International variations in social gradients in smoking, which are likely to be related to differences between countries in their stage of the smoking epidemic, may have contributed to the socioeconomic differences in mortality from ischaemic heart disease being greater in northern European countries.
The Lancet Infectious DiseasesPopulation-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
629 Citations2015Mélanie Drolet, Élodie Bénard +28 more
Cochrane Database of Systematic ReviewsProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
599 Citations2018Marc Arbyn, Lan Xu +2 more
Efficacy endpoints by initial HPV DNA statushrHPV negativeHPV vaccines reduce CIN2+, CIN3+, AIS associated with HPV16/18 compared with placebo in adolescent girls and women aged 15 to 26 and most women were under 26 years of age.
The LancetCervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
578 Citations2007P Appleby, Valerie Beral +9 more
The relative risk of cervical cancer is increased in current users of oral contraceptives and declines after use ceases, and by 10 or more years had returned to that of never users.
Methods in molecular biologyThe Swedish Multi-generation Register
533 Citations2010Anders Ekbom
The Swedish Multi-generation Register consists of data of more than nine million individuals, with information available on mothers in 97% and on fathers in 95% of index persons.
Canadian Medical Association JournalMissing covariate data in clinical research: when and when not to use the missing-indicator method for analysis
503 Citations2012Rolf H. H. Groenwold, Ian R. White +4 more
Two approaches to reduce statistical noise in epidemiologic and clinical research by including in the analysis only those participants without missing observations (complete or available case analysis).
Clinical Infectious DiseasesImpact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
473 Citations2016Suzanne M. Garland, Susanne K. Kjær +12 more
Substantial reductions in HPV 6/11/16/18 infection, anogenital warts, and cervical lesions have been achieved.
Cancer Causes & ControlSmoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study
448 Citations2003Martyn Plummer, Rolando Herrero +6 more
Smoking increases the risk of cervical cancer among HPV positive women, and recent increasing trends of smoking among young women could have a serious impact on cervical cancer incidence in the coming years.
The Annals of StatisticsPiecewise Exponential Models for Survival Data with Covariates
213 Citations1982Michaël Friedman
Nature Reviews Clinical OncologyClinical trials of human papillomavirus vaccines and beyond
179 Citations2013Matti Lehtinen, Joakim Dillner
A strong increase in vaccine efficacy with increasing severity of the precancerous lesion is explained by accumulation of the most-oncogenic HPV types 16 and 18 in these lesions, and prophylactic HPV vaccination will exceed the best results from screening for cancer.
International Journal of CancerVaccination protects against invasive HPV‐associated cancers
169 Citations2017Tapio Luostarinen, Dan Apter +7 more
Ten cases with invasive carcinomas a priori established as cancers caused by HPV are found in nonHPV vaccinated women but no cases in HPV vaccinated women, and the overall vaccine efficacy estimate 100% is statistically significant albeit with somewhat wide confidence interval due to the small end-point frequencies.
JNCI Journal of the National Cancer InstituteQuadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
145 Citations2013Amy Levál, Eva Herweijer +8 more
Young age at first vaccination is imperative for maximizing quadrivalent HPV vaccine effectiveness, and GW rates declined among the unvaccinated, suggesting that HPV vaccines were preferentially used by women at high risk of GW.
American Journal of Preventive MedicineCervical Cancer Incidence in Young U.S. Females After Human Papillomavirus Vaccine Introduction
144 Citations2018Fangjian Guo, Leslie E. Cofie +1 more
A significant decrease in the incidence of cervical cancer among young females after the introduction of human papillomavirus vaccine may indicate early effects of human Papillomvirus vaccination.
International Journal of CancerQuadrivalent <scp>HPV</scp> vaccine effectiveness against high‐grade cervical lesions by age at vaccination: A population‐based study
131 Citations2016Eva Herweijer, Karin Sundström +4 more
High effectiveness of qHPV vaccination on CIN2+ and CIN3+ lesions is shown, with greater effectiveness observed in girls younger at vaccination initiation, with stronger results for both women participating to the organized screening program and for women at prescreening ages.
Biometrical JournalTesting the Ratio of Two Poisson Rates
113 Citations2008Kangxia Gu, Hon Keung Tony Ng +2 more
Four different general approaches for testing the ratio of two Poisson rates are compared and some recommendations favoring the likelihood ratio and certain asymptotic tests are based on these simulation results.
European Journal of Cancer PreventionThe association between BMI and cervical cancer risk
94 Citations2015Jalal Poorolajal, Ensiyeh Jenabi
The findings from this meta-analysis indicate that overweight is not associated with a increased risk of cervical cancer, but obesity is weakly associated with an increased riskof cervical cancer.
PLoS MedicineHigh-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
74 Citations2018Jiayao Lei, Alexander Ploner +8 more
Preventive MedicineMode of HPV vaccination delivery and equity in vaccine uptake: A nationwide cohort study
63 Citations2018Jiangrong Wang, Alexander Ploner +5 more
Free-of-charge school-based HPV vaccination achieved the highest uptake and displayed the least disparity in country of birth and socioeconomic background of the parents, appearing to be the most effective and equitable delivery mode for reaching high population vaccination coverage.
International Journal of CancerImpact of an HPV6/11/16/18 L1 virus‐like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection
62 Citations2011Richard M. Haupt, Cosette M. Wheeler +13 more
The data suggest HPV vaccination neither reduces nor enhances progression to HPV16/18‐related high grade cervical lesions, and cervical cytology screening and corresponding management should continue as per local recommendations.
The Lancet Child & Adolescent HealthEffectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study
59 Citations2018Michael J. Silverberg, Wendy A. Leyden +7 more
Catch-up quadrivalent HPV vaccination with three doses was effective against CIN2+ and CIN3+ in girls and women aged 14-20 years at time of first vaccine dose but not for women aged 21 years and older at first dose.
PLoS ONEThe Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study
47 Citations2015Eva Herweijer, Adina L. Feldman +7 more
HPV-vaccination is so far associated with equal or higher attendance to cervical screening in Sweden in a cohort of opportunistically vaccinated young women, most but not all of the difference in attendance was explained by socioeconomic differences between vaccinated and unvaccinated women.
VaccineFactors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study
31 Citations2015Karen Canfell, Sam Egger +5 more
In this group, women living in higher socioeconomic status areas were more likely to be vaccinated against HPV in the catch-up phase of the national program, reinforcing the continuing need to prioritise equitable delivery of vaccination to various population subgroups.
VaccineSubstantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden
28 Citations2018Eva Herweijer, Alexander Ploner +1 more
Despite low population vaccination coverage in women and no coverage in men, similar condyloma incidence reductions were observed among men and women, with delays of >1 years in men.
BMJ OpenOpportunistic HPV vaccination at age 16–23 and cervical screening attendance in Sweden: a national register-based cohort study
27 Citations2018Teresa Kreusch, Jiangrong Wang +2 more
HPV- vaccinated women were more likely to attend screening than unvaccinated women, and the question needs to be reassessed in routinely vaccinated cohorts, since the vaccinated women included here represent a selected group and may be prone to more health-conscious habits.
VaccineHPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009–2014
7 Citations2016Maria E. Sundaram, Susan M. Mason +1 more
No evidence that high BMI is associated with reduced initiation or completion of the HPV vaccination series, or age at initiation of the three-dose course among a general population sample of US adolescents is found, suggesting efforts to increase HPV vaccine uptake need not consider targeting by weight status at this time.
International Journal of CancerErratum
4 Citations2017
A mistake was detected in the analysis of a backdating period for histological CIN21 lesions in order to account for HPV vaccination occurring close to the disease event, which led to misclassification of exposure due to the indolent nature of CIN lesions.